The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model

Anwar Jagessar; Z Fagrouch; N Heijmans; J Bauer; Jon Laman; L Oh; T Migone; EJ Verschoor; Boris Hart

doi:10.1007/s11481-013-9448-6

The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model

Anwar Jagessar, Z Fagrouch, N Heijmans, J Bauer, Jon Laman, L Oh, T Migone, EJ Verschoor, Boris Hart

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	727-738
Number of pages	12
Journal	Journal of NeuroImmune Pharmacology
Volume	8
Issue number	3
DOIs	https://doi.org/10.1007/s11481-013-9448-6
Publication status	Published - 2013

Research programs

EMC MM-02-72-02

Access to Document

10.1007/s11481-013-9448-6

http://hdl.handle.net/1765/39466

Cite this

Jagessar, A., Fagrouch, Z., Heijmans, N., Bauer, J., Laman, J., Oh, L., Migone, T., Verschoor, EJ., & Hart, B. (2013). The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model. Journal of NeuroImmune Pharmacology, 8(3), 727-738. https://doi.org/10.1007/s11481-013-9448-6

@article{fa5b00252c014803b4884e734c91f9ca,

title = "The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model",

author = "Anwar Jagessar and Z Fagrouch and N Heijmans and J Bauer and Jon Laman and L Oh and T Migone and EJ Verschoor and Boris Hart",

year = "2013",

doi = "10.1007/s11481-013-9448-6",

language = "Undefined/Unknown",

volume = "8",

pages = "727--738",

journal = "Journal of NeuroImmune Pharmacology",

issn = "1557-1890",

publisher = "Springer",

number = "3",

}

Jagessar, A, Fagrouch, Z, Heijmans, N, Bauer, J, Laman, J, Oh, L, Migone, T, Verschoor, EJ & Hart, B 2013, 'The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model', Journal of NeuroImmune Pharmacology, vol. 8, no. 3, pp. 727-738. https://doi.org/10.1007/s11481-013-9448-6

The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model. / Jagessar, Anwar; Fagrouch, Z; Heijmans, N et al.
In: Journal of NeuroImmune Pharmacology, Vol. 8, No. 3, 2013, p. 727-738.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of gamma-Herpesvirus Infected B Cells in the Marmoset EAE Model

AU - Jagessar, Anwar

AU - Fagrouch, Z

AU - Heijmans, N

AU - Bauer, J

AU - Laman, Jon

AU - Oh, L

AU - Migone, T

AU - Verschoor, EJ

AU - Hart, Boris

PY - 2013

Y1 - 2013

U2 - 10.1007/s11481-013-9448-6

DO - 10.1007/s11481-013-9448-6

M3 - Article

C2 - 23508625

SN - 1557-1890

VL - 8

SP - 727

EP - 738

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

IS - 3

ER -